You are here: All Products  > CASI Pharma Pays $7.7 Million for Global Rights to CD38 Immunotherapy

CASI Pharma Pays $7.7 Million for Global Rights to CD38 Immunotherapy

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products